Gökçe E, Beyhan M. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors. World J Radiol 2023; 15(1): 20-31 [PMID: 36721673 DOI: 10.4329/wjr.v15.i1.20]
Corresponding Author of This Article
Erkan Gökçe, MD, Professor, Department of Radiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Kaleardı Neighborhood, Muhittin Fisunoglu Street, Tokat 60100, Turkey. drerkangokce@gmail.com
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Radiol. Jan 28, 2023; 15(1): 20-31 Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Table 1 Locations, numbers, and frequencies of salivary gland tumors
Location
n (%)
Unilateral parotid gland
61 (83.6)
Submandibular gland
6 (8.2)
Minor salivary gland
3 (4.1)
Bilateral parotid gland
2 (2.7)
Sublingual gland
1 (1.4)
Table 2 Numbers of benign and malignant salivary gland tumors
Benign SGTs
n (%)
Malignant SGTs
n (%)
Warthin’s tumor
18 (24.7)
Squamous cell carcinoma
11 (15.1)
Pleomorphic adenoma
14 (19.2)
Adenoid cystic carcinoma
3 (4.1)
Inflammatory process
12 (16.4)
Malignant lymphoma
3 (4.1)
Lipoma
4 (5.5)
Adenocarcinoma
1 (1.4)
Benign cystic lesions
1 (1.4)
Mucoepidermoid carcinoma
1 (1.4)
Carcinoma ex pleomorphic adenoma
1 (1.4)
Other benign lesions
1 (1.4)
Acinic cell carcinoma
1 (1.4)
Follicular dendritic cell sarcoma
1 (1.4)
Salivary duct carcinoma
1 (1.4)
Total
50 (68.5)
23 (31.5)
Table 3 Mean ADC values and quantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors
Pleomorphic adenoma
Warthin’s tumor
Other benign tumors
Malignant tumors
P value
ADC (× 10−3 mm2/s)
1.61 ± 0.26 (a)
0.72 ± 0.09 (b)
0.77 ± 0.19 (b)
0.96 ± 0.33 (b)
< 0.001
Ktrans (min−1)
0.42 ± 0.35
0.75 ± 0.55
0.57 ± 0.37
0.77 ± 0.56
0.131
Kep (min−1)
0.69 ± 0.33 (a)
6.2 ± 3.13 (b)
1.95 ± 0.94 (c)
1.72 ± 0.92 (c)
< 0.001
Ve
0.65 ± 0.25 (a)
0.11 ± 0.04 (b)
0.3 ± 0.12 (c)
0.48 ± 0.24 (ac)
< 0.001
Table 4 Semiquantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors
TIC Pattern, n(%)
Tpeak (s)
WR (%)
A
B
C
D
Pleomorphic adenomas
14 (70.0)
0 (0)
0 (0)
0 (0)
202.74 ± 21.48 (a)
-
Warthin’s tumors
0 (0)
18 (66.7)
0 (0)
0 (0)
20.26 ± 11.72 (b)
59.33 ± 10.99 (a)
Other benign tumors
4 (20.0)
4 (14.8)
10 (45.5)
0 (0)
74.94 ± 75.47 (c)
17.89 ± 14.99 (b)
Malignant tumors
2 (10.0)
5 (18.5)
12 (54.5)
4 (100)
60.60 ± 55.78 (c)
18.48 ± 18.38 (b)
P value
< 0.001
< 0.001
< 0.001
Table 5 Comparison of pleomorphic adenomas, Warthin’s tumors, and malignant salivary gland tumors by ROC analysis using ADC, Tpeak, Ktrans, Kep, and Ve values
Variable
Cut-off
AUC (95% CI)
Sensitivity
Specificity
PPV
NPV
P value
Pleomorphic adenomas
ADC value
> 1.1
0.977 (0.911-0.998)
1.000
0.898
0.700
1.000
< 0.001
Tpeak
> 120
0.947 (0.868-0.986)
1.000
0.898
0.700
1.000
< 0.001
Ktrans
≤ 0.46
0.702 (0.584-0.804)
0.857
0.627
0.353
0.949
0.005
Kep
≤ 1.14
0.926 (0.840-0.974)
0.929
0.831
0.565
0.980
< 0.001
Ve
≥ 0.4
0.849 (0.746-0.922)
0.929
0.729
0.448
0.977
< 0.001
Warthin’s tumors
ADC value
≤ 0.8
0.742 (0.626-0.837)
0.944
0.582
0.425
0.970
< 0.001
Tpeak
≤ 19.1
0.869 (0.769-0.936)
0.667
0.909
0.706
0.893
< 0.001
WR
> 43
0.981 (0.917-0.999)
0.944
0.909
0.773
0.980
< 0.001
Ktrans
> 0.3
0.577 (0.455-0.692)
0.889
0.346
0.308
0.905
0.291
Kep
> 2.44
0.973 (0.905-0.997)
1.000
0.855
0.692
1.000
< 0.001
Ve
≤ 0.17
0.958 (0.883-0.991)
1.000
0.909
0.783
1.000
< 0.001
Malignant tumors
ADC value
> 0.7
0.541 (0.420-0.658)
0.783
0.440
0.391
0.815
0.569
Tpeak
≤ 120
0.531 (0.410-0.649)
0.913
0.360
0.396
0.900
0.648
WR
≤ 49
0.562 (0.441-0.678)
1.000
0.300
0.397
1.000
0.351
Ktrans
> 0.53
0.599 (0.477-0.712)
0.652
0.600
0.429
0.789
0.194
Kep
≤ 3.7
0.592 (0.471-0.706)
1.000
0.300
0.397
1.000
0.160
Ve
> 0.35
0.702 (0.584-0.804)
0.696
0.660
0.485
0.825
0.001
Citation: Gökçe E, Beyhan M. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors. World J Radiol 2023; 15(1): 20-31